Analyst Research

Report Title Price
Provider: New Constructs, LLC
Provider: S&P Capital IQ Quantitative Report
Provider: Pechala's Reports
Provider: Pechala's Reports

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Auxilium Pharmaceuticals Inc Raises FY 2013 Guidance-Conference Call

Monday, 29 Apr 2013 08:30am EDT 

Auxilium Pharmaceuticals Inc announced that for fiscal 2013, it expects total revenues of $360 million to $415 million. According to I/B/E/S Estimates, analysts were expecting the Company to report revenue of $348 million for fiscal 2013. 

Company Quote

0.28 +1.53%
29 Aug 2014